AI-Powered Corneal Graft Assessment for Eye Banks and Transplantation Centers
KerifAI
Innovation Award Winner – Étoiles de l’Europe
Designed for Eye Banks & Transplant Surgeons
AI-Powered Ex-vivo Corneal Tissues Assessment
Every donor cornea matters. Assessing graft quality accurately and consistently is essential to maximize the availability of transplantable tissues and improve patient outcomes. Yet current evaluation methods often rely on manual observations, subjective interpretations, and time-consuming workflows.
KerifAI leverages artificial intelligence and computer vision to automate the assessment of donor corneas, providing objective, reproducible, and quantitative measurements that support eye banks and transplantation professionals in making more informed decisions. Developed through a collaboration between the Rouen University Hospital Tissue Bank, EFF’INNOV Technologies, and ADCIS, KerifAI brings together expertise in medicine, research, and AI to modernize corneal tissue evaluation.
Transform donor cornea images into objective quality indicators and optimize tissues quality assessment process.
Improve Tissue Qualification. Reduce Waste.
Eye banks face increasing demands for efficiency, traceability, and reproducible tissue evaluation. Variability in assessments can lead to inconsistent decisions and potentially usable tissues being discarded.
KerifAI helps eye banks organizations :
- Standardize corneal tissues assessment
- Generate objective and reproducible measurements
- Support tissue qualification decisions
- Reduce operator variability
- Increase transparency in graft evaluation
- Improve traceability and reporting
By automating image analysis and providing quantitative biomarkers, KerifAI delivers a new level of precision in corneal tissue evaluation.
Designed for Eye Banks, Surgeons and Researchers
KerifAI combines advanced image analysis, artificial intelligence, and ophthalmology expertise to simplify graft assessment.
Key Capabilities
- AI-powered tissue quality assessment
- Endothelial cells counting
- Endothelial cells density
- Endothelial cells morphology
- Corneal tissue size measurment
- Decision-support tools for eye banks
- Traceable report generation
- Quantitative data structuration
- Advanced analytical module for research
- Integration into clinical and research workflows
The result is a faster, more reliable, and more reproductible.
Who Benefits from KerifAI?
From Corneal Imaging
to Better Patient Outcomes
KerifAI was created with a simple objective: use artificial intelligence to improve ex-vivo corneal tissues assessment. By providing accurate and reproducible tissue assessments, the solution helps eye banks optimize graft selection, improve operational efficiency, and support better outcomes for patients waiting for a cornea transplant.
From donor tissue evaluation to transplantation readiness, KerifAI transforms image analysis into actionable clinical intelligence.
- Intuitive and easy to use collaborative web portal
- Objective and reproducible tissue evaluation
- Designed with leading corneal experts
- Optimized for eye banks
- Quantitative quality indicators
- Improved workflow efficiency
- Better support for transplantation decisions
- Award-winning healthcare innovation
- Donor Cornea Qualification
- Eye Bank Quality Control
- Corneal Tissue Evaluation
- Transplant Readiness Assessment
- AI-Assisted Graft Analysis
- Corneal Research Programs
- Clinical Study Endpoints
- Digital Transformation of Eye Banks
Reduce Tissue Waste.
Increase Transplant Opportunities.
Leverage AI-powered corneal assessment
to make more confident graft qualification decisions.